 | Up a level |
Yamamoto, Masanori; Hayashida, Kentaro; Hengstenberg, Christian; Watanabe, Yusuke; Van Mieghem, Nicolas M; Jin, James; Saito, Shigeru; Valgimigli, Marco; Nicolas, Johny; Mehran, Roxana; Moreno, Raul; Kimura, Tetsuya; Chen, Cathy; Unverdorben, Martin; Dangas, George D (2023). Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation. The American journal of cardiology, 207, pp. 150-158. Elsevier 10.1016/j.amjcard.2023.08.067
Van Mieghem, Nicolas M; Unverdorben, Martin; Hengstenberg, Christian; Möllmann, Helge; Mehran, Roxana; López-Otero, Diego; Nombela-Franco, Luis; Moreno, Raul; Nordbeck, Peter; Thiele, Holger; Lang, Irene; Zamorano, José L; Shawl, Fayaz; Yamamoto, Masanori; Watanabe, Yusuke; Hayashida, Kentaro; Hambrecht, Rainer; Meincke, Felix; Vranckx, Pascal; Jin, James; ... (2021). Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. The New England journal of medicine, 385(23), pp. 2150-2160. Massachusetts Medical Society 10.1056/NEJMoa2111016
Van Mieghem, Nicolas M; Unverdorben, Martin; Valgimigli, Marco; Mehran, Roxana; Boersma, Eric; Baber, Usman; Hengstenberg, Christian; Shi, Minggao; Chen, Cathy; Saito, Shigeru; Veltkamp, Roland; Vranckx, Pascal; Dangas, George D (2018). Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. American Heart Journal, 205, pp. 63-69. Elsevier 10.1016/j.ahj.2018.07.006
